CDI Receives MDEL In Canada for Non-Invasive Diagnostic Breath Tests
Commonwealth Diagnostics International, Inc. (CDI), the leader in hydrogen and methane breath testing® for functional gastrointestinal disorders, announces its entry into the Canadian healthcare market. CDI will offer its state-of-the-art, non-invasive, functional GI diagnostic tests to the approximately five million Canadians afflicted with Irritable Bowel Syndrome (IBS)1, and millions of other patients suffering from functional…